Open Label Phase I Clinical Trial of Crotoxin in Patients With Advanced Cancer Using an Intravenous Route of Administration
Phase of Trial: Phase I
Latest Information Update: 24 Jul 2017
At a glance
- Drugs Crotoxin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Celtic Biotech
- 18 Jul 2017 Planned number of patients changed from 24 to 18.
- 18 Jul 2017 Planned End Date changed from 1 May 2017 to 1 Jul 2018.
- 18 Jul 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2018.